Skip to main content
search

Early Clinical

Sign up

Latest resources

Featured resource

Upcoming early clinical webinars

Webinar

What is new in Phoenix 8.9?

November 17, 2026 – 10:00 - 11:00am ET
Webinar

Explore Smarter, Faster PK/PD with Phoenix

November 17, 2026 – 10-11 AM ET/CET/JST
Webinar

Transforming drug interaction evaluation workflows with DIDB

December 2, 2026 – 11:00am - 12:00pm ET

Latest early clinical blogs

Meet our experts at the following events

Conference

PHUSE EU Connect

November 15 - 18, 2026 – Glasgow, UK
Conference

JSSX 2026 in Japan

November 17 - 19, 2026
Conference

2nd Model-Informed Drug Development Summit

November 18 - 19, 2026 – Wyndham Boston Beacon Hil, Boston, MA

All early clinical resources

Accelerating GLP-1 Drug Development: How Metsera, Certara & Altasciences Reached Phase 2

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Case Study

From PK Data to Document: An AI-Driven Daytrip with Phoenix Cloud

Certara Products - Phoenix, Modeling and Simulation - PK/PD, Webinar

What is new in Phoenix 8.9?

Certara Products - Phoenix, Certara University, Clinical Pharmacology, Modeling and Simulation - PK/PD, Webinar

Leveraging a QSP Platform for Prediction of Clinical Efficacy and Safety Biomarkers in Immuno-Oncology Combination Therapy

Modeling and Simulation - QSP, Publication

2nd Model-Informed Drug Development Summit

Certara Products, Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Therapeutic Specialties, Conference

From Data to Decisions: Getting More from Clinical Trial Evidence

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Webinar

Drug-Drug Interaction (DDI) Calculator

Drug Development, Drug-Drug Interactions (DDI), Model Informed Drug Development, Fact Sheet

Simultaneous Population PKPD Analysis of Belantamab Mafodotin, Soluble BCMA, and Serum M-Protein in Relapsed/Refractory Multiple Myeloma

Biologics, Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Oncology/Hematology, Therapeutic Specialties, Publication

2nd TCE for Autoimmune Disease Summit

Biologics, Certara Products - Certara IQ, Certara Services, Model Informed Drug Development, Modeling and Simulation - QSP, Conference

How Do You Know You Have the Right Dose? Using Exposure-Response Evidence to Justify and Defend Dose Decisions

Certara Products, Certara Products - Phoenix, Certara Services, Clinical Pharmacology, Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Webinar

From Biological Mechanisms to Causal Inference: Quantitative Systems Pharmacology and Causal Frameworks in Drug Development

Modeling and Simulation - QSP, Publication

Securing Pimicotinib Approval: How Abbisko Therapeutics Successfully Completed its NMPA and FDA Submissions with Pinnacle 21 Enterprise

Certara Products - Pinnacle 21, Case Study
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.